Publications or Presentations Sample Clauses

Publications or Presentations. Both Parties shall have the right to make public announcements regarding Licensed Product in accordance with Article 13 below. Furthermore, ▇▇▇▇▇▇▇ acknowledges that Genmab, its Affiliates or their employees, and certain Third Parties [***] may wish to present or publish parts of the Licensed Know-How in order to inform the scientific community or public of their work, and in principle agrees that such publication or presentation may be desirable, subject to balancing the benefits of such publication or presentation against any prejudice to the value of the rights and licenses granted to ▇▇▇▇▇▇▇ hereunder. In such cases, Genmab shall provide a copy to ▇▇▇▇▇▇▇’▇ Alliance Manager of the desired publication or presentation and ▇▇▇▇▇▇▇ shall consider the same in good faith. Genmab or its staff or [***] shall be permitted to submit such publication or make such presentation if ▇▇▇▇▇▇▇ gives its prior written consent (not to be unreasonably withheld or delayed). For the purposes of the foregoing, ▇▇▇▇▇▇▇ shall be deemed to have given its prior written consent to Genmab’s proposed publication or presentation if it does not notify Genmab in writing of its objection thereto within [***] calendar days of Genmab providing ▇▇▇▇▇▇▇’▇ Alliance Manager with a copy of the publication or presentation as set out above. If ▇▇▇▇▇▇▇ withholds such consent, the Parties shall discuss the situation in good faith with a view to amending such publication or presentation or to delay the publication for sufficient time to file a patent application, if necessary or possible, in order to overcome ▇▇▇▇▇▇▇’▇ objections. It is agreed that ▇▇▇▇▇▇▇ shall not be entitled to withhold consent to the publication or presentation of information which is already in the public domain, except to the extent that such publication or presentation would be inaccurate or misleading and thereby likely to prejudice the exercise by ▇▇▇▇▇▇▇ of its rights and licenses hereunder, and that ▇▇▇▇▇▇▇ shall not be entitled to withhold its consent hereunder in any manner or circumstances that would be incompatible or inconsistent with Genmab’s corresponding obligations to Third Parties under [***]. With respect to any proposed abstracts, manuscripts or summaries of presentations by investigators or other Third Parties, such materials shall be subject to review under this Clause 8.6 to the extent that Genmab has the right and ability (after using reasonable efforts) to do so.

Publications or Presentations. Notwithstanding anything set forth in this Agreement to the contrary, with respect to research and development activities conducted or sponsored by NK, whether through its employees, subcontractors, agents, or any academic, governmental, or other independent contractors, NK agrees that prior to making, allowing or authorizing any presentations or publications relating to the results of such activities (each individually a “Publication”) in the Territory or the NeoPharm Territory, NK shall provide NeoPharm with a copy of any proposed Publication at least thirty (30) days prior to such submission, presentation or publication thereof. NK will not submit, permit or authorize such a Publication without prior written consent of NeoPharm, which consent, however, shall not be unreasonably withheld. If NeoPharm fails to object to a proposed Publication within such thirty (30) day time period, NeoPharm shall be deemed to have consented to the submission, presentation or publication of such Publication.

Publications or Presentations. Clementia shall have the right to publish or otherwise present any Data or other results generated under this Agreement in its sole discretion.

Publications or Presentations